Dr. Goyal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1521 Cooper St
Fort Worth, TX 76104Phone+1 817-336-5864Fax+1 817-336-2159
Summary
- Dr. Vikas Goyal is a Pulmonary/Critical Care physician currently Baylor University Medical Center in Dallas, TX. He received his medical degree from University of Texas Medical Branch School of Medicine and has been in practice 7 years. He specializes in critical care medicine and pleural disease.
Education & Training
- Virginia Commonwealth University Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 2013 - 2016
- Virginia Commonwealth University Health SystemResidency, Internal Medicine, 2010 - 2013
- University of Texas Medical Branch School of MedicineClass of 2010
Certifications & Licensure
- TX State Medical License 2015 - 2026
- VA State Medical License 2013 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 1 citationsPhenotypic Features of Pediatric Bronchiectasis Exacerbations Associated With Symptom Resolution After 14 Days of Oral Antibiotic Treatment.Vikas Goyal, Stephanie T Yerkovich, Keith Grimwood, Julie M Marchant, Catherine A Byrnes
Chest. 2023-12-01 - 16 citationsEuropean Respiratory Society statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials.Anne B Chang, Angela Zacharasiewicz, Vikas Goyal, Jeanette Boyd, Efthymia Alexopoulou
The European Respiratory Journal. 2022-11-01 - 7 citationsBronchiectasis in Childhood.Vikas Goyal, Anne B Chang
Clinics in Chest Medicine. 2022-03-01
Press Mentions
- Amoxicillin/clavulanate Emerges as Best Antibiotic for Childhood BronchiectasisOctober 18th, 2019
- World Haemophilia Day ObservedApril 21st, 2019
- Study Identifies Which Bronchiectasis Patients Respond to AntibioticsJuly 19th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: